RG
Richard L Gabriel
Director

Richard L Gabriel insider trades: Predictive Oncology (POAI) stock purchases

Director, Predictive Oncology Last trade Sep 1, 2020 31 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2018
5
Companies
last trade 2020

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 1, 2020POAI↑ Buy$4K
Aug 19, 2020POAI↑ Buy$4K
Sep 5, 2019POAI↑ Buy$920
Aug 23, 2019POAI↑ Buy$2K
Dec 11, 2018AIPT↑ Buy$1K
Nov 28, 2018AIPT↑ Buy$2K
Nov 20, 2018AIPT↑ Buy$890

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Richard L Gabriel's insider trades

Richard L Gabriel is a director at Predictive Oncology (POAI). Since Nov 20, 2018, Richard has reported 7 open-market purchases worth $14K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (24 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every POAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.